节点文献
新型抗肿瘤药物治疗肺癌的研究进展
Advances of novel drugs for lung cancer
【摘要】 新型抗肿瘤药物不断推陈出新,彻底改写晚期肺癌的治疗格局,延长了患者的生存,推进了肺癌慢病化进程。本文拟对肺癌治疗领域包括靶向治疗、免疫治疗及抗血管生成治疗中的新型抗肿瘤药物及相关研究进展进行梳理汇总,旨在为临床用药提供参考。
【Abstract】 Novel anti-tumor drugs are constantly being introduced and have revolutionized the therapy landscape of lung cancer and prolonged the overall survival time of patients. And lung cancer may become a chronic disease in the future. In this review,we summarized the advances of novel drugs for lung cancer,including drugs of targeted therapy,immunotherapy and antiangiogenesis therapy,aiming at providing guidance for clinical application.
【关键词】 肺癌;
新型药物;
靶向治疗;
免疫治疗;
抗血管生成治疗;
【Key words】 lung cancer; novel drugs; targeted therapy; anti-angiogenesis; immunotherapy;
【Key words】 lung cancer; novel drugs; targeted therapy; anti-angiogenesis; immunotherapy;
- 【文献出处】 上海医药 ,Shanghai Medical & Pharmaceutical Journal , 编辑部邮箱 ,2022年S2期
- 【分类号】R734.2
- 【下载频次】410